Skip to
  1. Homepage
  2. Research and trials
  3. Research projects
Search by disease/gene

Search by disease/gene

*
(*) mandatory field


 

Other search option(s)

19 Result(s)

Partnership : Academics = Academics, Industrials = Industrials, Financial investitors = Financial investitors

    • CANADA
    • Colombie-Britannique
    • VANCOUVER
    • FORGE - Finding of Rare Disease Genes in Canada
    • University of British Columbia
    • Faculty of Medicine
    • More details
    • CANADA
    • Ontario
    • OTTAWA, ONTARIO
    • FORGE - Finding of Rare Disease Genes in Canada
    • University of Ottawa
    • Faculty of Medicine -
    • More details
    • CANADA
    • Québec
    • MONTREAL
    • FORGE - Finding of Rare Disease Genes in Canada
    • Centre hospitalier universitaire Sainte-Justine
    • Pédiatrie
    • More details
    • CYPRUS
    • Cyprus
    • NICOSIA
    • Analysis of new mutations in families with Charcot-Marie-Tooth disease
    • The Cyprus Institute of Neurology and Genetics
    • Laboratory of neurology and genetics
    • More details
    • CYPRUS
    • Cyprus
    • NICOSIA
    • Genetic characterization of CMT families in Cyprus
    • The Cyprus Institute of Neurology and Genetics
    • Laboratory of neurology and genetics
    • More details
    • ESTONIA
    • Tartu
    • TARTU
    • The prevalence and genetic background of hereditary hearing impairment in Estonia
    • Children's Clinic of Tartu University
    • Department of Paediatrics
    • More details
    • FRANCE
    • ILE-DE-FRANCE
    • PARIS
    • Genetical basis of Charcot-Marie-Tooth disease and hereditary neuropathies
    • CHU Paris-GH La Pitié Salpêtrière-Charles Foix - Hôpital Pitié-Salpêtrière
    • Institut du Cerveau et de la Moëlle épinière
    • More details
    • FRANCE
    • ILE-DE-FRANCE
    • PARIS
    • Characterization of new genes involved in non-syndromic and syndromic deafness (especially Usher syndrome) and corresponding impairement physiopathology
    • Institut Pasteur
    • Unité de Génétique et physiologie cellulaire
    • More details
    • FRANCE
    • RHONE-ALPES
    • BRON
    • Search for genes and mutations implicated in Charcot-Marie-Tooth disease, type 1
    • CHU de Lyon-GH Est - Hospices Civils de Lyon
    • UF de neurogénétique moléculaire
    • More details
    • GERMANY
    • Bayern
    • MÜNCHEN
    • BNE: BrainNet Europe II: European brain tissue bank - Network for clinical neuroscience and basic research (coordination)
    • Ludwig-Maximilians-Universität München
    • Zentrum für Neuropathologie und Prionforschung
    • More details
    • ITALY
    • LOMBARDIA
    • MILANO
    • Restoring cell-extracellular matrix interactions to rescue tissue degeneration and favor repair in hereditary neuropathies
    • IRCCS Ospedale San Raffaele - DIBIT
    • Unità di Neurobiologia Cellulare e Molecolare
    • More details
    • ITALY
    • VENETO
    • PADOVA
    • Pathogenetic mechanisms and therapeutic perspectives for connexin related hereditary hearing loss
    • Venetian Institute of Molecular Medicine
    • Centro Interdipartimentale per lo Studio dei Segnali Cellulari
    • More details
    • SPAIN
    • Comunidad Valenciana
    • VALENCIA
    • TREAT-CMT: Traslational Research, Experimental Medicine and Therapeutics of Charcot-Marie-Tooth Disease (coordination)
    • CIBERER
    • Centro de Investigación Biomédica en Red de Enfermedades Raras
    • More details
    • SPAIN
    • Comunidad Valenciana
    • VALENCIA
    • Traslational Research and disease mechanisms in hereditary peripheral neuropathies: development of a diagnostic tool for Charcot-Marie-Tooth, investigation of the cellular physiopathology of type 4C and characterization of a new hereditary recurrent neuropathy linked to SMYD4 gene
    • Centro de Investigación Príncipe Felipe (CIPF)
    • Laboratorio de Genética y Genómica de Enfermedades Neuromusculares
    • More details
    • SPAIN
    • Comunidad Valenciana
    • VALENCIA
    • TREAT-CMT: Traslational Research, Experimental Medicine and Therapeutics of Charcot-Marie-Tooth Disease - WP2: Translational genomics and identification of biomarkers for the diagnosis of CMT neuropathy
    • Centro de Investigación Príncipe Felipe (CIPF)
    • Laboratorio de Genética y Genómica de Enfermedades Neuromusculares
    • More details
    • SPAIN
    • Comunidad Valenciana
    • VALENCIA
    • TREAT-CMT: Traslational Research, Experimental Medicine and Therapeutics of Charcot-Marie-Tooth Disease - WP3: Cellular routes, physiopathology and therapeutics of CMT neuropathy associated with mitochondria
    • Centro de Investigación Príncipe Felipe (CIPF)
    • Laboratorio de Genética y Genómica de Enfermedades Neuromusculares
    • More details
    • SPAIN
    • Comunidad Valenciana
    • VALENCIA
    • TREAT-CMT: Traslational Research, Experimental Medicine and Therapeutics of Charcot-Marie-Tooth Disease - WP1: Natural history, phenotyping and clinical research tools
    • Hospital Universitario y Politécnico La Fe
    • Servicio de Neurología (H. La Fe)
    • More details
    • SPAIN
    • Comunidad Valenciana
    • VALENCIA
    • Rationalisation of molecular diagnosis of the Charcot-Marie-Tooth neuropathy
    • Instituto de Biomedicina de Valencia (CSIC)
    • Unidad de Genética y Medicina Molecular
    • More details
    • UNITED KINGDOM
    • Greater London
    • LONDON
    • Strengthening hip flexors to improve walking distance in people with Charcot Marie Tooth Disease
    • National Hospital for Neurology and Neurosurgery
    • MRC Centre for Neuromuscular Disease and Department of Molecular Neurosciences
    • More details